Health News

Microbiology & Infectious Diseases Asia Congress, 10th & 11th June 2014, Singapore

Date: Jan-28-2014
New Addition To Oxford Global Asia Events in 2014: Microbiology and Infectious Disease Asia Congress As global concern grows over drug-resistant infections and the prevalence of infectious diseases, researchers are looking to enhance capabilities for pathogen detection, infection diagnosis and genomic analysis of disease-causing micro-organisms. With this, Oxford Global Conferences are proud to the present the first ever Microbiology & Infectious Diseases Asia Congress, taking place on the 10 & 11 June 2014 in Singapore.

Medical Devices Summit, February 24-26, 2014, Boston, MA

Date: Jan-28-2014
With the current volatility of the health care industry, many medical device manufacturers are plagued with questions and concerns about their products. Opal Events' 5th Annual Medical Devices Summit strives to bring together industry and regulatory professionals from across the country to address key issues in compliance, quality and innovation. Medical device manufacturers are tasked with staying on top of regulatory updates, competitive designs and new opportunities- and can find them all in one place at this celebrated event!

New classification system for breast cancers

Date: Jan-28-2014
Breast cancer tumors have long been classified according to their expression of three surface proteins: estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor (HER2).These classifications are used to determine best treatments and prognoses, but are not adequate to describe tumor characteristics or compare them to normal breast tissue. In this issue of the Journal of Clinical Investigation, Tan Ince and colleagues of the University of Miami devised a method to categorize normal breast tissue cells as a reference point to classify tumor cells.

Disrupted sleep speeds up cancer

Date: Jan-28-2014
Researchers in the US found of two groups of mice given the same cancer-inducing treatment, the group whose sleep was disrupted developed larger, more aggressive tumors than the well-rested mice.In the journal Cancer Research, the team also reports how they found the immune system of the sleep-disrupted mice was less effective at fighting the early stages of cancer than the immune system of the well-rested mice.Study director Prof. David Gozal says:"It's not the tumor, it's the immune system.

UCB launches online challenge to find next generation of breakthrough medicines

Date: Jan-28-2014
UCB has announced the global launch of its 'Innovation Challenge', reinforcing its role as a pioneering science-skills leader. This new online challenge seeks to find rare phenotypes - for example, people who are somehow protected from disease or possess exceptional tissue regeneration. By better understanding the molecular basis of a rare phenotype, UCB scientists hope to be able to develop new medicines for the treatment of severe diseases such as rheumatoid arthritis or multiple sclerosis.

Short course immunotherapy effective in reducing ragweed pollen allergy

Date: Jan-28-2014
Allergy Therapeutics, has announced that a paper entitled "Efficacy of a short course of specific immunotherapy in patients with allergic rhinoconjunctivitis to ragweed pollen" is now available in the print edition of The Journal of Allergy and Clinical Immunology, the peer reviewed, high impact journal. The trial was conducted between May 2005 - Jan 2006.

EnVivo Pharmaceuticals initiates COGNITIV AD, a Phase 3 clinical trial program of encenicline (EVP-6124) in Alzheimer's disease

Date: Jan-28-2014
EnVivo Pharmaceuticals, a company dedicated to developing a broad range of novel therapies for central nervous system (CNS) diseases, has announced it has initiated COGNITIV AD, a Phase 3 clinical program evaluating its novel alpha-7 (α7) potentiator, encenicline-hydrochloride (EVP-6124), in patients with Alzheimer's disease (AD). The program is being conducted under a Special Protocol Assessment agreement with the FDA.

New biomedical diagnostics using personalized 3D imaging

Date: Jan-28-2014
This innovation enables 3D images of living organisms to be obtained with greater speed and precision. In broad terms, helical optical projection tomography consists in rotating a sample while moving it vertically in order to then obtain a three-dimensional image of it, explain its creators.

Tracheotomies faster and safer

Date: Jan-28-2014
The new device, which was patented by researchers of the School of Industrial Engineering of the Universidad Politécnica de Madrid (UPM) in collaboration with the Universidad Autónoma de Madrid (UAM), has achieved minimizing the risks associated to emergency tracheotomies and the time needed to perform planned tracheotomies. This is possible thanks to the combination of mechanical and drilling devices with medical imaging elements and information management that it would allow the adaptation of the surgery to the physical conditions of the patient.

New method increases supply of embryonic stem cells

Date: Jan-28-2014
A new method allows for large-scale generation of human embryonic stem cells of high clinical quality. It also allows for production of such cells without destroying any human embryos. The discovery is a big step forward for stem cell research and for the high hopes for replacing damaged cells and thereby curing serious illnesses such as diabetes and Parkinson's disease.Currently human embryonic stem cells are made from surplus in vitro fertilized (IVF) embryos that are not used for the generation of pregnancies. The embryos do not survive the procedure.